Ironwood Pharmaceuticals, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2022 | $273.8M | $273.6M | $136.0K | $27.0M |
| FY2023 | $183.4M | $183.2M | $273.0K | $32.0M |
| FY2024 | $103.5M | $103.4M | $142.0K | $29.9M |
| FY2025 | $127.0M | $127.0M | $34.0K | $17.3M |